Metraipolis › archive › dc_dcdff7f8916e

TDP2 drives immune evasion and metastatic progression in prostate cancer — Europe PMC PMID:41481587

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41481587
DOI: 10.1371/journal.pone.0339607
License (as archived): solo-consultazione
Archived: 2026-11-07T02:38:50.612Z
SHA-256 of the archived text: b9f00122b8f646fcaa7ed570521fbbb8f558c64608cdf82292279b0a12e54a32
Stable URL of this page: https://metraipolis.com/documento/dc_dcdff7f8916e

How to cite

TDP2 drives immune evasion and metastatic progression in prostate cancer — Europe PMC PMID:41481587 — Europe PMC (en), https://europepmc.org/article/MED/41481587 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dcdff7f8916e (Metraipolis archive dc_dcdff7f8916e, sha256 b9f00122b8f646fcaa7ed570521fbbb8f558c64608cdf82292279b0a12e54a32)

BibTeX

@misc{dcdcdff7f8916e,
  title = {TDP2 drives immune evasion and metastatic progression in prostate cancer — Europe PMC PMID:41481587},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41481587},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dcdff7f8916e; sha256 b9f00122b8f646fcaa7ed570521fbbb8f558c64608cdf82292279b0a12e54a32},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41481587. Agents can read the archived copy with the MCP tool read_document.